2OMQ

vealyl peptide derived from human insulin chain b, residues 12-17

• Total interactions analyzed: 6
• Total true interactions: 6
• Strongest Interaction:
  • Chains: C-D
  • Int. Res.: 12
  • Norm. En. per Res.: -11.8567
• Hub Node: A(3)

All Interactions

Chains	Hydro. Bond Ener. (kJ/mol)	Elec. Ener. (kJ/mol)	VDW. Ener. (kJ/mol)	Tot. Stab. Ener. (kJ/mol)	#int. res.	# Short cont.	#Hydr. int.	#VDW pairs	#salt bridges	#Pot. fav. elec. int	#Pot. unfav. elec. int
A-B	-53.5007	0.0	-73.7275	-127.2282	12	7	5	2563	0	0	1
A-C	0.0	0.0	-15.3786	-15.3786	10	2	2	665	0	0	1
A-D	0.0	0.0	-0.0957	-0.0957	5	0	0	48	0	0	0
B-C	0.0	0.0	-17.069	-17.069	10	0	2	781	0	0	0
B-D	-12.5295	0.0	-13.8119	-26.3414	9	2	2	652	0	0	1
C-D	-63.1943	0.0	-79.0866	-142.2809	12	5	5	2682	0	0	1

Interface residues

• A-B: ALA3A, ALA3B, GLU2A, GLU2B, LEU4A, LEU4B, LEU6A, LEU6B, TYR5A, TYR5B, VAL1A, VAL1B
• A-C: ALA3A, ALA3C, GLU2A, GLU2C, LEU4A, LEU4C, LEU6C, TYR5A, TYR5C, VAL1A
• A-D: ALA3D, TYR5A, TYR5D, VAL1A, VAL1D
• B-C: ALA3B, ALA3C, GLU2B, GLU2C, LEU4B, LEU4C, LEU6B, LEU6C, TYR5B, TYR5C
• B-D: ALA3D, GLU2B, GLU2D, LEU4B, LEU4D, LEU6B, TYR5B, TYR5D, VAL1D
• C-D: ALA3C, ALA3D, GLU2C, GLU2D, LEU4C, LEU4D, LEU6C, LEU6D, TYR5C, TYR5D, VAL1C, VAL1D